Tredje Ap Fonden Edwards Lifesciences Corp Transaction History

Tredje Ap Fonden

$10.2 Billion
Q2 2024

A detailed history of Tredje Ap Fonden transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Tredje Ap Fonden holds 194,156 shares of EW stock, worth $12.7 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

194,156

Previous 216,156 10.18%

Holding current value

$12.7 Million

Previous $20.7 Million 13.17%

% of portfolio

0.17%

Previous 0.22%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$84.3 - $94.31 $1.85 Million - $2.07 Million	-22,000 Reduced 10.18%	194,156 $17.9 Million
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $3.41 Million - $4.49 Million	47,000 Added 27.79%	216,156 $20.7 Million
Q4 2023 Feb 12, 2024	BUY	$61.71 - $77.76 $1.51 Million - $1.91 Million	24,500 Added 16.94%	169,156 $12.9 Million
Q3 2023 Nov 09, 2023	SELL	$69.28 - $93.38 $556,249 - $749,748	-8,029 Reduced 5.26%	144,656 $10 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $3.32 Million - $3.85 Million	-40,820 Reduced 21.1%	152,685 $14.4 Million
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $3.06 Million - $3.48 Million	41,216 Added 27.06%	193,505 $16 Million
Q4 2022 Feb 10, 2023	BUY	$68.3 - $87.44 $6.17 Million - $7.9 Million	90,383 Added 146.0%	152,289 $11.4 Million
Q3 2022 Nov 10, 2022	SELL	$82.37 - $107.29 $4.34 Million - $5.66 Million	-52,733 Reduced 46.0%	61,906 $5.12 Million
Q1 2022 May 09, 2022	BUY	$101.96 - $128.34 $2.49 Million - $3.13 Million	24,400 Added 27.04%	114,639 $13.5 Million
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $876,382 - $1.08 Million	8,239 Added 10.05%	90,239 $11.7 Million
Q3 2021 Nov 10, 2021	BUY	$102.91 - $122.75 $5.71 Million - $6.81 Million	55,500 Added 209.43%	82,000 $9.28 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $11.7 Million - $14.8 Million	-162,662 Reduced 85.99%	26,500 $2.42 Million
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $7.26 Million - $9.7 Million	126,108 Added 200.0%	189,162 $13.1 Million
Q1 2020 May 11, 2020	BUY	$52.41 - $81.0 $2.39 Million - $3.7 Million	45,666 Added 262.63%	63,054 $6.88 Million
Q4 2019 Feb 10, 2020	SELL	$71.7 - $82.09 $59,224 - $67,806	-826 Reduced 4.53%	17,388 $4.06 Million
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $97,618 - $119,631	-1,586 Reduced 8.01%	18,214 $4.01 Million
Q2 2019 Aug 09, 2019	SELL	$55.74 - $64.41 $67,779 - $78,322	-1,216 Reduced 5.79%	19,800 $3.66 Million
Q1 2019 May 10, 2019	BUY	$47.89 - $64.05 $237,869 - $318,136	4,967 Added 30.95%	21,016 $4.02 Million
Q4 2018 Feb 11, 2019	BUY	$46.41 - $56.94 $42,233 - $51,815	910 Added 6.01%	16,049 $2.46 Million
Q3 2018 Nov 13, 2018	BUY	$45.7 - $58.03 $110,594 - $140,432	2,420 Added 19.03%	15,139 $2.64 Million
Q2 2018 Aug 09, 2018	SELL	$42.45 - $51.3 $307,168 - $371,206	-7,236 Reduced 36.26%	12,719 $1.85 Million
Q1 2018 May 09, 2018	SELL	$37.19 - $47.45 $5,578 - $7,117	-150 Reduced 0.75%	19,955 $2.78 Million
Q4 2017 Feb 12, 2018	SELL	$33.79 - $39.39 $4,392 - $5,120	-130 Reduced 0.64%	20,105 $2.27 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $734,328 - $785,725	20,235	20,235 $2.21 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.

Account